AI-generated summary
The authors used a theoretical melanosome disruption model to calculate required fluence and collateral tissue energy for picosecond lasers at 532 to 1064 nm with large spot sizes. They also reported a small clinical case series of two dermal lesions treated with a 1064 nm laser, which showed good clearance without adverse events. The authors state that increased device energy output may be needed for sufficient efficacy, and the evidence is largely simulation-based.
- Who or what was studied
- Pigmented lesions in Asian skin, including an ectopic Mongolian spot and a nevus of Ota in the clinical case series
- Wavelengths
- 532, 730, 755, 785, 1064 nm
- Limits stated in the abstract
- Primarily theoretical modeling, with clinical validation limited to a small case series of two dermal lesions.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 1064 nm, 532 nm, 730-1064 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Fluence, Near-infrared, Wavelength. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.